The Paris MASH Meeting on September 5th and 6th will unveil the latest knowledge and advancements in MASH research, setting the stage for the future of MASH medicine. Join leading MASH key opinion leaders (KOLs) just a few days later to hear their panel discussion of the critical findings and advancements shared at the meeting and what they believe we can expect as MASH research continues. Whether you are a seasoned professional or new to MASH, this discussion will equip you with the knowledge and tools necessary to excel in MASH research.
Key topics include:
o Greatest takeaways from the Paris MASH meeting
o Epidemiology & public health burden of MASH
o Emerging concepts in liver rehabilitation & improving metabolic health outcomes
o AI application, ethical consideration & care delivery optimization
o Best practices in disease monitoring of MASH
Register for this webinar to stay on top of the rapidly evolving field of MASH research and gain insights from the leading MASH KOLs.
HOST:
Michael Betel
President & Founder, Fatty Liver Alliance
Learn more about Michael: https://fattyliver.ca/our-board
PANELISTS:
Attila Timar-Peregrin, MD, PhD, DVProf
Executive Director, Medical Affairs & Therapeutic Area Lead, Digestive Diseases
Worldwide Clinical Trials
Learn more about Dr. Timar-Peregrin: https://www.worldwide.com/about-us/meet-the-team/attila-timar-peregrin/
Jörn Schattenberg, MD
Professor of Medicine & Director of the Metabolic Liver Research Program
University Medical Center Mainz
Learn more about Dr. Schattenberg: https://academicmedicaleducation.com/jorn-m-schattenberg-md.
Naim Alkhouri, MD, FAASLD
Chief Medical Officer, Chief of Transplant Hepatology, & Director of the Fatty Liver Program
Arizona Liver Health
Learn more about Dr. Alkhouri: https://azliver.com/dr-naim-alkhouri/
Mark Swain, MD
Professor of Medicine, Cumming School of Medicine
University of Calgary
Learn more about Dr. Swain: https://profiles.ucalgary.ca/mark-gordon-swain
Presented by